NVS

Novartis News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Novartis AG NVS NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
1.01 1.07% 95.63 20:00:00
Open Price Low Price High Price Close Price Prev Close
95.61 95.42 96.54 95.63 94.62
more quote information »

Recent News

Date Time Source Heading
1/14/202107:07DJNNovartis Gets FDA Breakthrough-Therapy Designation for..
1/12/202109:25DJNTwitter, Tesla, Realty Income: What to Watch When the Stock..
1/12/202108:36DJNTwitter, Tesla, Realty Income: What to Watch When the Stock..
1/12/202107:33DJNTwitter, Tesla, Realty Income, Cantel Medical: What to Watch..
1/11/202118:08DJNBeiGene to Collaborate With Novartis on Tislelizumab, Will..
1/11/202108:12DJNEli Lilly, Twitter, NIO: What to Watch When the Stock Market..
12/21/202007:38TRMNNovartis’ Cholesterol Drug Fails To Get FDA Approval; Shares..
12/17/202002:45DJNNovartis to Acquire Neuroscience Company Cadent for Up to..
12/15/202002:09DJNNovartis's Beovu Meets Phase-3 Primary Endpoint
12/14/202002:07DJNNovartis's Ruxolitinib Didn't Meet Primary Endpoint in Phase..
12/08/202011:00DJNNovartis Says Asciminib Showed Superior MMR Rate to Bosulif..
12/01/202012:26DJNNovartis, Genentech Get Expanded FDA OK of Xolair for Nasal..
11/24/202002:01DJNNovartis to Repurchase Up to $2.5 Billion in Shares
11/19/202017:53DJNMesoblast Up 25% After Hours on Collaboration With Novartis
11/19/202017:23EDGARSecurities Registration: Employee Benefit Plan (s-8)
11/19/202006:00DJNNovartis Signs Five Contracts as Part of Green Energy Push
11/06/202002:12DJNNovartis CAN-Covid Trial on Coronavirus Patients Didn't Meet..
11/02/202002:18DJNNovartis Phase 4 Migraine Study Meets Primary, Secondary..
10/28/202003:03DJNNovartis, Molecular Partners to Develop Therapies for..
10/27/202007:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/27/202006:09DJNNovartis Raises Core Operating Income View As Virus Drag..
10/27/202003:04DJNNovartis 3Q Profit Fell, Raises Outlook for Core Operating..
10/20/202008:45NNWBanking on the Next Blockbuster Drug
10/16/202008:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/06/202009:10DJNMerck KGaA to Outlicense Osteoarthritis Clinical Program for..
10/06/202008:40DJNEMA Accepts Biogen, Samsung Bioepis Filing for Lucentis..
10/05/202005:59DJNCompanies Test a New Type of ESG Bond With Fewer..
9/23/202006:05EDGARReport of Foreign Issuer (6-k)
9/17/202004:58DJNBioNTech to Buy German Novartis Site to Expand Covid-19..
9/16/202014:00PRNUSNovartis US Foundation commits $25M to improve health equity..
9/09/202013:00DJNNovartis, Roche, Genentech Get Joint EUR444 Million Fine..
9/09/202007:09DJNNovartis, Roche, Genentech Get Joint EUR444 Million Fine..
9/01/202006:06EDGARReport of Foreign Issuer (6-k)
8/26/202003:02DJNTeva Indicted in Price Case -- WSJ
8/25/202022:14DJNTeva Pharmaceutical's U.S. Unit Indicted on Price-Fixing..
8/25/202020:43DJNTeva Pharmaceutical's U.S. Unit Indicted on Price-Fixing..
8/25/202019:57DJNTeva Pharmaceutical's U.S. Unit Indicted on Price-Fixing..
8/25/202018:57DJNTeva Pharmaceutical's U.S. Unit Indicted on Price-Fixing..
8/24/202001:51DJNNovartis's Spartalizumab Phase 3 Combi-i Trial Didn't Meet..
8/21/202002:03DJNNovartis: Multiple-Sclerosis Drug Kesimpta Gets FDA Approval
8/20/202014:22EDGARReport of Foreign Issuer (6-k)
8/18/202003:23DJNNovartis's Gilenya Dosage Regimen Patent Upheld in US Court..
8/17/202014:16EDGARReport of Foreign Issuer (6-k)
8/13/202010:04DJNNovartis, Genentech: FDA to Review Xolair..
7/27/202004:14DJNNovartis's Sandoz, Austrian Government to Invest EUR150..
7/21/202004:08DJNNovartis Adjusts Outlook After Second-Quarter Income and..
7/21/202002:15DJNNovartis Second-Quarter Income and Sales Fell as Stockpiling..
7/16/202001:56DJNNovartis To Offer Zero-Profit Medicines For Covid-19..
7/01/202021:38DJNNovartis Finalizes Settlement of Speaker Program Litigation..
7/01/202019:40DJNNovartis Finalizes Settlement of Speaker Program Litigation..
See more news about this stock »


Your Recent History
NYSE
NVS
Novartis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.